Role of Hiraoka's transurethral detachment of the prostate combined with biopsy of the peripheral zone during the same session in patients with repeated negative biopsies in the diagnosis of prostate cancer

Table 1 Data of the cohort

Characteristics	Results
Follow-up period (mo)	35.0 (12.0–40.0)
No. of cases	10
Age (yr)	66.0 (62.0–67.0)
BMI (kg/m2)	26.0 (24.0–27.0)
Familial history of PCa	0 (0)
Number of negative biopsy (times)	2 (2–3)
Prostate volume (mL)	55.0 (40.0–60.0)
Pathological examination (PCa)	2 (0.2)
PSA pre-operation (ng/mL)	19.10 (16.00 to 23.00)
PSA 3 mo postoperation	1.00 (1.05–1.20)
PSA 1 year postoperation	1.15 (1.10–1.20)

Data are presented as the median (IQRs) or number (percentages). BMI: Body mass index; PCa: Prostate cancer; IQR: Interquartile range.